Nitrated type III collagen as a biological marker of nitric oxide-mediated synovial tissue metabolism in osteoarthritis

Osteoarthritis and Cartilage

Volumn 17, Issue 10, 2009, Pages 1362-1367

  Richardot, P ^a   Charni Ben Tabassi, N ^a   Toh, L ^b   Marotte, H ^b   Bay Jensen, A C ^c   Miossec, P ^b   Garnero, P ^a,d  

^a Synarc   (France)

^b EDOUARD HERRIOT HOSPITAL   (France)

^c UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^d INSERM   (France)

Author keywords

Biological marker; Nitric oxide; Osteoarthritis; Synovium; Type III collagen

Indexed keywords

AMINO TERMINAL TELOPEPTIDE; BIOLOGICAL MARKER; C REACTIVE PROTEIN; COLLAGEN TYPE 3; NITRIC OXIDE; POLYCLONAL ANTIBODY;

ADULT; AGED; AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; KNEE OSTEOARTHRITIS; MAJOR CLINICAL STUDY; MALE; METABOLISM; NITRATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN LOCALIZATION; RHEUMATOID ARTHRITIS; SCORING SYSTEM; SYNOVIUM;

AGED; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; COLLAGEN TYPE I; COLLAGEN TYPE III; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NITRATES; OSTEOARTHRITIS, KNEE; PEPTIDES; SYNOVIAL MEMBRANE; TYROSINE;

EID: 70349386224     PISSN: 10634584     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joca.2009.04.024     Document Type: Article

References (25)

1. Gordon G.V., Villnueava T., Schumacher H.R., and Gohel V. Autopsy study correlating degree of osteoarthritis, synovitis and evidence of articular calcification. J Rheumatol 11 (1984) 681-686
2. Ayral X., Pickering E.H., Woodworth T.G., Mackillop N., and Dougados M. Synovitis: a potential predictive factor of structural progression of medial tibiofemoral knee osteoarthritis - results of a 1 year longitudinal arthroscopic study in 422 patients. Osteoarthritis Cartilage 13 (2005) 361-367
3. Jang D., and Murrell G.A. Nitric oxide in arthritis. Free Radic Biol Med 24 (1998) 1511-1519
4. Van' t Hof R.J., and Ralston S.H. Nitric oxide and bone. Immunology 103 (2001) 255-261
5. Stefanovic-Racic M., Stadler J., Georgescu H.I., and Evans C.H. Nitric oxide synthesis and its regulation by rabbit synoviocytes. J Rheumatol 21 (1994) 1892-1898
6. Abramson S.B., Amin A.R., Clancy R.M., and Attur M. The role of nitric oxide in tissue destruction. Best Pract Res Clin Rheumatol 15 (2001) 831-845
7. Beckman J.S., and Koppenol W.H. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 271 (1996) C1424-C1437
8. Mapp P.I., Klocke R., Walsh D.A., Chana J.K., Stevens C.R., Gallagher P.J., et al. Localization of 3-nitrotyrosine to rheumatoid and normal synovium. Arthritis Rheum 44 (2001) 1534-1539
9. Sandhu J.K., Robertson S., Birnboim H.C., and Goldstein R. Distribution of protein nitrotyrosine in synovial tissues of patients with rheumatoid arthritis and osteoarthritis. J Rheumatol 30 (2003) 1173-1181
10. Garnero P., Rousseau J.C., and Delmas P.D. Molecular basis and clinical use of biochemical markers of bone, cartilage, and synovium in joint diseases. Arthritis Rheum 43 (2000) 953-968
11. Gineyts E., Garnero P., and Delmas P.D. Urinary excretion of glucosyl-galactosyl pyridinoline: a specific biochemical marker of synovium degradation. Rheumatology 40 (2001) 315-323
12. Garnero P., Piperno M., Gineyts E., Christgau S., Delmas P.D., and Vignon E. Cross-sectional evaluation of biochemical markers of bone, cartilage and synovial tissue metabolism in patients with knee osteoarthritis: relations with disease activity and joint damage. Ann Rheum Dis 60 (2001) 619-626
13. Garnero P., Gineyts E., Christgau S., Finck B., and Delmas P.D. Association of baseline levels of urinary glucosyl-galactosyl-pyridinoline and type II collagen c-telopeptide are associated with progression of joint destruction in patients with early rheumatoid arthritis. Arthritis Rheum 46 (2002) 2847-2856
14. Altman R., Asch E., Bloch D., Bole G., Borenstein D., Brandt K., et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum 29 (1986) 1039-1049
15. Ahlbäck S. Osteoarthrosis of the knee. A radiographic investigation. Acta Radiol Diagn 277 Suppl (1968) 7-72
16. Arnett F.C., Edworthy S.M., Bloch D.A., McShane D.J., Fries J.F., Cooper N.S., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31 (1988) 315-324
17. Charni N., Juillet F., and Garnero P. Urinary type II collagen helical peptide (HELIX-II) as a new biochemical marker of cartilage degradation in patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum 52 (2005) 1081-1090
18. Chan W.C., and White P.A. Fmoc Solid Phase Peptide Synthesis: a Practical Approach (2000), Oxford University Press, Oxford
19. Harlow E., and Lane D. Antibodies: a Laboratory Manual (1988), Laboratory Press, Cold Spring Harbor (NY) pp. 72-87
20. Wang Z., Paik D.C., Dillon J.P., and Gaillard E.R. Tyrosine nitration site specificity identified by LC/MS in nitrite-modified collagen type IV. Exp Mol Med 39 (2007) 74-83
21. Charni-Ben Tabassi N, Richardot P, Toh L, Marotte H, Bay-Jensen AC, Miossec P, et al. Circulating nitrated N-telopeptide of type III collagen (IIINys) as a biochemical marker of oxidative-related synovial tissue metabolism in rheumatoid arthritis. Ann Rheum Dis 2009;68:451-2.
22. Del Carlo Jr. M., and Loeser R.F. Nitric oxide-mediated chondrocyte cell death requires the generation of additional reactive oxygen species. Arthritis Rheum 46 2 (2002 Feb) 394-403
23. Loeser R.F., Carlson C.S., Del Carlo M., and Cole A. Detection of nitrotyrosine in aging and osteoarthritic cartilage: correlation of oxidative damage with the presence of interleukin-1beta and with chondrocyte resistance to insulin-like growth factor 1. Arthritis Rheum 46 9 (2002 Sep) 2349-2357
24. Deberg M., Dubuc J.E., Labasse A., Sanchez C., Quettier E., Bosseloir A., et al. One-year follow-up of Coll2-1, Coll2-1NO2 and myeloperoxydase serum levels in osteoarthritis patients after hip or knee replacement. Ann Rheum Dis 67 2 (2008 Feb) 168-174
25. Henrotin Y., Deberg M., Dubuc J.E., Quettier E., Christgau S., and Reginster J.Y. Type II collagen peptides for measuring cartilage degradation. Biorheology 41 3-4 (2004) 543-547